FDA Drug Application (022223) for TRIESENCE by ALCON RES

Back to FDA Applications sponsored by ALCON RES

Application Number022223
Product Number001
FormINJECTABLE; SUSPENSION
Dosage40MGML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code TBD
Reference Drug
Drug NameTRIESENCE
Active IngredientTRIAMCINOLONE ACETONIDE



Back to FDA Applications sponsored by ALCON RES

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.